10 reports of this reaction
3.6% of all SODIUM BICARBONATE, SODIUM CHLORIDE reports
#2 most reported adverse reaction
DYSPNOEA is the #2 most commonly reported adverse reaction for SODIUM BICARBONATE, SODIUM CHLORIDE, manufactured by CVS Pharmacy. There are 10 FDA adverse event reports linking SODIUM BICARBONATE, SODIUM CHLORIDE to DYSPNOEA. This represents approximately 3.6% of all 278 adverse event reports for this drug.
Patients taking SODIUM BICARBONATE, SODIUM CHLORIDE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is moderately reported among SODIUM BICARBONATE, SODIUM CHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to dyspnoea, the following adverse reactions have been reported for SODIUM BICARBONATE, SODIUM CHLORIDE:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 10 FDA reports for SODIUM BICARBONATE, SODIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 3.6% of all adverse event reports for SODIUM BICARBONATE, SODIUM CHLORIDE, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking SODIUM BICARBONATE, SODIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.